SG Americas Securities
PCVX icon

SG Americas Securities’s Vaxcyte PCVX Stock Holding History

SG Americas Securities’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Sell
26,740
-5,472
-17% -$297K ﹤0.01% 1631
2026
Q1 		$1.87M Buy
32,212
+11,783
+58% +$640K ﹤0.01% 1431
2025
Q4 		$943K Sell
20,429
-5,129
-20% -$229K ﹤0.01% 2069
2025
Q3 		$921K Buy
25,558
+14,421
+129% +$478K ﹤0.01% 1542
2025
Q2 		$362K Sell
11,137
-3,383
-23% -$111K ﹤0.01% 1876
2025
Q1 		$548K Buy
14,520
+5,520
+61% +$441K ﹤0.01% 1701
2024
Q4 		$737K Sell
9,000
-530
-6% -$52.6K ﹤0.01% 1036
2024
Q3 		$1.09M Buy
9,530
+7,188
+307% +$648K ﹤0.01% 1022
2024
Q2 		$177K Sell
2,342
-2,017
-46% -$137K ﹤0.01% 2233
2024
Q1 		$298K Buy
+4,359
New +$302K ﹤0.01% 1695
2023
Q4 		– Sell
-27,980
Closed -$1.43M – 3352
2023
Q3 		$1.43M Buy
+27,980
New +$1.38M 0.02% 981
2023
Q2 		– Sell
-50,626
Closed -$1.9M – 2956
2023
Q1 		$1.9M Buy
50,626
+23,256
+85% +$986K 0.02% 697
2022
Q4 		$1.31M Buy
27,370
+12,098
+79% +$475K 0.02% 796
2022
Q3 		$367K Sell
15,272
-1,073
-7% -$27.2K ﹤0.01% 1817
2022
Q2 		$356K Buy
+16,345
New +$378K ﹤0.01% 2251
2022
Q1 		– Sell
-10,155
Closed -$242K – 3323
2021
Q4 		$242K Sell
10,155
-15,515
-60% -$361K ﹤0.01% 2568
2021
Q3 		$651K Buy
+25,670
New +$622K ﹤0.01% 2278
2021
Q2 		– Sell
-6,714
Closed -$133K – 3144
2021
Q1 		$133K Buy
+6,714
New +$169K ﹤0.01% 2928

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SG Americas Securities's PCVX Position: Q2 2026 in Review

SG Americas Securities reduced its Vaxcyte (PCVX) stake by 17% in Q2 2026, selling an estimated $297K and leaving 26,740 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

SG Americas Securities first reported a position in PCVX in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.9M in Q1 2023. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • SG Americas Securities held 26,740 shares of Vaxcyte worth $1.55M as of Q2 2026.
  • SG Americas Securities sold 5,472 Vaxcyte shares in Q2 2026, an estimated $297K.
  • Vaxcyte made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1631 holding.
  • SG Americas Securities first reported a position in Vaxcyte in Q1 2021 and has held it in 18 quarters since.
  • SG Americas Securities's Vaxcyte position peaked at $1.9M in Q1 2023.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.